Back to Search Results- Recruiting
- Treatment
- Interventional
- Randomized
- Radiation
- PHASE2
- Centre hospitalier de l'Université de Montréal (CHUM)
- -
Study Purpose
To determine if fBT+sRT is superior to standard care in terms of urinary toxicity by having fewer patients experience a minimal important decline (MID) in urinary irritation/obstructive QoL
Intervention
Radiation : focal brachytherapy boost to SBRT
Eligibility Requirements
Histological diagnosis of prostate cancer planned for curative-intent HDR brachytherapy boost to external beam radiotherapy to the prostate gland.
ECOG 0-1
Charlson Comorbidity Index ≤ 4
Imaging visible disease encompassing \< 50% of the prostate gland and consistent with biopsy findings.
Exclusion - none
Minimum age: 18
N/A
Recruiting status
Recruiting
Estimated enrollment
150
Study start date
Jul 01, 2019
Study end date
Jun 30, 2025
Last updated
Mar 23, 2025
Primary purpose
Treatment
Design
Interventional
Intervention
Radiation
Study phase
PHASE2
Allocation
Randomized
Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator:
N/A
Investigator:
N/A
N/A
Publications
N/A
Websites
N/A
NCT04100174
| Clinic | Location | Investigator | Distance | RECRUITING STATUS | Contact |
|---|